Countdown to 2021 CBIIC:

Charles CHAU

Partner of Jones Day (Hong Kong Office)

Charles Chau is a partner of the Hong Kong Office of Jones Day. In the past 19 years, he has represented clients in more than 180 transactions across a range of public and private mergers and acquisitions, joint ventures, financings and pre-IPO investments, a number of which focused on the medical, healthcare, and biotech industries. Charles has also advised Chinese companies on their outbound acquisitions. Prior to joining Jones Day, he acted for China CNR Corporation Limited in its US$26 billion merger with CSR Corporation Limited, which was the first merger of two companies listed in both Hong Kong and Shanghai. In addition, he worked on many IPOs and securities placement transactions, including the IPOs of Sinopharm Group, GenScript Biotech Corporation, BBI Life Sciences Corporation, China CNR Corporation, Guodian Technology & Environment Group, and the A+H rights issue of China CITIC Bank. He is now acting for a pre-revenue NEEQ-listed biotech company on its listing on the Main Board of the Hong Kong Stock Exchange.